OXFORD INSTRUMENTS PLC ORD GBP0.05OXFORD INSTRUMENTS PLC ORD GBP0.05OXFORD INSTRUMENTS PLC ORD GBP0.05

OXFORD INSTRUMENTS PLC ORD GBP0.05

No trades
See on Supercharts
Market capitalization
‪1.21 B‬GBP
‪58.60 M‬GBP
‪444.70 M‬GBP
‪54.46 M‬
Beta (1Y)
1.10

About OXFORD INSTRUMENTS PLC ORD GBP0.05

CEO
John Richard Tyson
Headquarters
Abingdon
Founded
1963
ISIN
GB0006650450
FIGI
BBG000BDWZZ7
Oxford Instruments Plc is a holding company, which engages in the provision of high-technology products and systems to companies and scientific research communities. It operates through the following segments: Materials and Characterisation; Research and Discovery; and Service and Healthcare. The Materials and Characterization segment focuses on applied research and development and commercial customers which enables the fabrication and characterisation of materials and devices down to the atomic scale. The Research and Discovery segment offers advanced solutions that create unique environments and enable measurements down to the molecular and atomic level which are used in fundamental research. The Service and Healthcare segment includes customer service and support for the products and the service of third-party healthcare imaging systems. The company was founded by Martin Francis Wood and Audrey Wood in 1959 and is headquartered in Abingdon, the United Kingdom.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of OXIG is 2060.00 GBX — it has decreased by 1.44% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange OXFORD INSTRUMENTS PLC ORD GBP0.05 stocks are traded under the ticker OXIG.
OXFORD INSTRUMENTS PLC ORD GBP0.05 is going to release the next earnings report on Jun 11, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for OXFORD INSTRUMENTS PLC ORD GBP0.05 has a max estimate of 29.00 GBX and a min estimate of 21.50 GBX.
OXIG earnings for the last quarter are 0.62 GBX whereas the estimation was 0.59 GBX which accounts for 5.27% surprise. Estimated earnings for the next quarter are 0.50 GBX. See more details about OXFORD INSTRUMENTS PLC ORD GBP0.05 earnings.
OXFORD INSTRUMENTS PLC ORD GBP0.05 revenue for the last quarter amounts to ‪244.20 M‬ GBX despite the estimated figure of ‪247.50 M‬ GBX. In the next quarter revenue is expected to reach ‪203.80 M‬ GBX.
Yes, you can track OXFORD INSTRUMENTS PLC ORD GBP0.05 financials in yearly and quarterly reports right on TradingView.
Like other stocks, OXIG shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade OXFORD INSTRUMENTS PLC ORD GBP0.05 stock right from TradingView charts — choose your broker and connect to your account.
OXIG reached its all-time high on May 10, 2023 with the price of 2884.80 GBX, and its all-time low was 98.85 GBX and was reached on Mar 26, 2003.
See other stocks reaching their highest and lowest prices.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. OXFORD INSTRUMENTS PLC ORD GBP0.05 EBITDA is ‪82.20 M‬ GBP, and current EBITDA margin is 19.52%. See more stats in OXFORD INSTRUMENTS PLC ORD GBP0.05 financial statements.